JPMORGAN CHASE & CO - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$1,452,257
-74.6%
154,990
-33.6%
0.00%
-100.0%
Q2 2023$5,728,221
+94.8%
233,519
+84.8%
0.00%
Q1 2023$2,941,000
+77560.4%
126,355
-15.5%
0.00%
Q4 2022$3,787
-99.8%
149,619
+78.9%
0.00%
Q3 2022$1,613,000
-23.6%
83,635
+0.8%
0.00%
Q2 2022$2,112,000
+2.7%
82,956
+3.7%
0.00%
Q1 2022$2,057,000
-73.0%
79,973
-56.0%
0.00%
-100.0%
Q4 2021$7,613,000
-4.2%
181,822
-0.4%
0.00%0.0%
Q3 2021$7,946,000
-20.1%
182,576
-13.2%
0.00%0.0%
Q2 2021$9,939,000
-7.7%
210,228
+0.0%
0.00%0.0%
Q1 2021$10,773,000
+176.9%
210,139
+44.6%
0.00%0.0%
Q4 2020$3,891,000
-12.2%
145,298
+23.6%
0.00%0.0%
Q3 2020$4,434,000
-10.9%
117,523
-3.3%
0.00%0.0%
Q2 2020$4,978,000
+19.4%
121,531
-0.1%
0.00%0.0%
Q1 2020$4,169,000
+232.2%
121,655
+22.0%
0.00%
Q4 2019$1,255,00099,7410.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders